Michael Haggerson is an intellectual property associate with experience in a wide range of disciplines, including machine learning and artificial intelligence, digital therapeutics, biomedical engineering, surgical systems and medical devices, tissue engineering, and orthopedics. Mike counsels' clients in the strategic development and protection of intellectual property portfolios and conducts due diligence, freedom-to-operate, and patentability analyses, as well as preparing and prosecuting patents in the United States and internationally. He also assists in post-grant matters before the Patent Trial and Appeal Board (PTAB) and provides strategic analysis in patent litigation matters. He also counsels' clients on IP-issues in business transactions.
Michael counsels clients on:
- Strategically developing and extracting value from intellectual property portfolios on a wide range of technologies, including medical devices, robotic and computer-assisted surgical systems, digital therapeutics, artificial intelligence, ingestible sensors, and 3D bioprinting.
- Transactions involving intellectual property, including reviewing agreements and conducting due diligence analyses.
- Performing patentability, freedom to operate, infringement, and other analyses.
- J.D., University of Pittsburgh
- B.S.E., Biomedical Engineering, University of Michigan
- Co-author, "Developing, Disclosing, and Patenting Technology During National Emergencies," The Licensing Journal, June/July 2020
- Co-author, "Implementing Berkheimer: shifting the examination burden at the USPTO," K&L Gates, July 2018